CELZ insider filings
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. — 24 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-25. Screen CELZ transaction legs live →
Insider transaction summary — last 90 days
2026-08-23 to 2026-11-21, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Warbington Timothy — President & CEO, Director, 10% owner & Creative Acquisition Corp. — Director | 1 | — | — | 1 |
Recent insider filings — CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-25 | 4 | Warbington Timothy — President & CEO, Director, 10% owner Creative Acquisition Corp. — Director | Grant/award (A): 1,000,000 | EDGAR |
| 2025-02-20 | 4 | Finger Michael H. — Director | Sale (S): 750 @ $5 · Sale (S): 750 @ $5.75 | EDGAR |
| 2023-06-29 | 4 | Warbington Timothy — President & CEO, Director | Purchase (P): 300 @ $4.40 · Purchase (P): 300 @ $4.45 · Purchase (P): 200 @ $4.48 · Purchase (P): 200 @ $4.36 | EDGAR |
| 2022-11-23 | 4 | Warbington Timothy — President & CEO, Director | Purchase (P): 10,000 @ $0.40 · Purchase (P): 5,000 @ $0.39 · Purchase (P): 9,800 @ $0.39 · Purchase (P): 200 @ $0.38 | EDGAR |
| 2022-09-29 | 4 | Finger Michael H. — Director | Purchase (P): 2,000 @ $0.50 | EDGAR |
| 2022-09-28 | 4 | Warbington Timothy — President & CEO, Director | Purchase (P): 20,000 @ $0.50 | EDGAR |
| 2022-09-22 | 4 | Warbington Timothy — President & CEO, Director | Purchase (P): 5,000 @ $0.61 · Purchase (P): 4,500 @ $0.64 · Purchase (P): 500 @ $0.63 · Purchase (P): 20,000 @ $0.60 · Purchase (P): 12,000 @ $0.54 | EDGAR |
| 2022-06-14 | 4 | Finger Michael H. — Director | Purchase (P): 10,000 @ $0.70 | EDGAR |
| 2022-06-07 | 4 | Warbington Timothy — President & CEO, Director | Purchase (P): 2,000 @ $0.92 · Purchase (P): 8,000 @ $0.92 · Purchase (P): 15,000 @ $0.91 | EDGAR |
| 2022-05-20 | 4 | Finger Michael H. — Director | Purchase (P): 6,500 @ $1.50 | EDGAR |
| 2022-02-11 | 4 | Warbington Timothy — President & CEO, Director | Grant/award (A): 58,580 (derivative) @ $0 | EDGAR |
| 2022-02-11 | 4 | Dickerson Donald — CFO & Sr. VP, Director | Grant/award (A): 53,237 (derivative) @ $0 | EDGAR |
| 2021-07-22 | 4 | Ichim Thomas — Director | Sale (S): 1,400,000 @ $0.03 · Sale (S): 1,500,000 @ $0.03 · Sale (S): 1,450,000 @ $0.03 | EDGAR |
| 2021-07-16 | 4 | Ichim Thomas — Director | Grant/award (A): 5,000,000 (derivative) @ $0 | EDGAR |
| 2021-07-16 | 4 | Patel Amit Nilkanth — Director | Grant/award (A): 5,000,000 (derivative) @ $0 | EDGAR |
| 2021-07-16 | 4 | Dickerson Donald — CFO & Sr. VP, Director | Grant/award (A): 5,000,000 (derivative) @ $0 | EDGAR |
| 2021-06-29 | 4 | Ichim Thomas — Director | Option exercise (M): 10,000,000 @ $0.00 · Tax withholding (F): 1,120,448 @ $0.04 · Option exercise (M): 10,000,000 (derivative) @ $0 | EDGAR |
| 2021-01-08 | 4 | Warbington Timothy — President & CEO, Director, 10% owner | Other (J): 44,642,857 | EDGAR |
| 2021-01-08 | 4 | CREATIVE MEDICAL HEALTH INC. — 10% owner | Other (J): 44,642,857 | EDGAR |
| 2020-12-31 | 4 | Dickerson Donald — CFO & Sr. VP, Director | Grant/award (A): 10,000,000 (derivative) @ $0 | EDGAR |
| 2020-12-31 | 4 | Patel Amit Nilkanth — Director | Grant/award (A): 10,000,000 (derivative) @ $0 | EDGAR |
| 2020-12-31 | 4 | Ichim Thomas — Director | Grant/award (A): 10,000,000 (derivative) @ $0 | EDGAR |
| 2020-10-02 | 4 | CREATIVE MEDICAL HEALTH INC. — 10% owner | Other (J): 42,328,042 | EDGAR |
| 2020-10-02 | 4 | Warbington Timothy — President & CEO, Director, 10% owner | Other (J): 42,328,042 | EDGAR |
Recent 8-K events — CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-13 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-31 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-31 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-19 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-31 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-05-06 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-04-11 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CELZ returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs